←Back to Expert Scholars
Translational Medicine / 转化医学Primary CNS Lymphoma, Neuro-Oncology
Lakshmi Nayak
MD
🏢Dana-Farber Cancer Institute🌐USA
Director, Center for CNS Lymphoma
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lakshmi Nayak directs the Center for CNS Lymphoma at Dana-Farber and leads trials of checkpoint inhibitors and novel agents in PCNSL. She has pioneered nivolumab-based therapy for relapsed CNS lymphoma. Her work expands immunotherapy options for patients with CNS involvement.
Share:
🧪Research Fields 研究领域
primary CNS lymphoma
immunotherapy PCNSL
nivolumab CNS lymphoma
secondary CNS lymphoma
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lakshmi Nayak 的研究动态
Follow Lakshmi Nayak's research updates
留下邮箱，当我们发布与 Lakshmi Nayak（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment